Zhejiang Dayang Biology Technology Co.,Ltd.
003017.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥910 | CN¥919 | CN¥1,058 | CN¥783 |
| % Growth | -1% | -13.1% | 35.1% | – |
| Cost of Goods Sold | CN¥732 | CN¥753 | CN¥912 | CN¥631 |
| Gross Profit | CN¥178 | CN¥166 | CN¥146 | CN¥152 |
| % Margin | 19.6% | 18.1% | 13.8% | 19.4% |
| R&D Expenses | CN¥29 | CN¥39 | CN¥34 | CN¥28 |
| G&A Expenses | CN¥18 | CN¥65 | CN¥14 | CN¥16 |
| SG&A Expenses | CN¥21 | CN¥75 | CN¥22 | CN¥24 |
| Sales & Mktg Exp. | CN¥3 | CN¥10 | CN¥9 | CN¥7 |
| Other Operating Expenses | CN¥53 | -CN¥1 | CN¥33 | CN¥27 |
| Operating Expenses | CN¥103 | CN¥110 | CN¥90 | CN¥79 |
| Operating Income | CN¥75 | CN¥56 | CN¥59 | CN¥79 |
| % Margin | 8.3% | 6.1% | 5.6% | 10.1% |
| Other Income/Exp. Net | -CN¥4 | -CN¥9 | -CN¥2 | -CN¥3 |
| Pre-Tax Income | CN¥72 | CN¥47 | CN¥57 | CN¥76 |
| Tax Expense | CN¥8 | -CN¥3 | -CN¥23 | CN¥6 |
| Net Income | CN¥64 | CN¥50 | CN¥81 | CN¥70 |
| % Margin | 7% | 5.4% | 7.6% | 8.9% |
| EPS | 0.78 | 0.62 | 0.99 | 0.83 |
| % Growth | 25.8% | -37.4% | 19.3% | – |
| EPS Diluted | 0.78 | 0.62 | 0.99 | 1.16 |
| Weighted Avg Shares Out | 81 | 81 | 81 | 60 |
| Weighted Avg Shares Out Dil | 82 | 81 | 82 | 60 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥9 | CN¥8 | CN¥1 | CN¥1 |
| Interest Expense | CN¥7 | CN¥7 | CN¥6 | CN¥4 |
| Depreciation & Amortization | CN¥69 | CN¥70 | CN¥60 | CN¥45 |
| EBITDA | CN¥147 | CN¥123 | CN¥123 | CN¥125 |
| % Margin | 16.2% | 13.4% | 11.6% | 16% |